Search by Drug Name or NDC

    NDC 42291-0739-30 Solifenacin Succinate 5 mg/1 Details

    Solifenacin Succinate 5 mg/1

    Solifenacin Succinate is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by AvKARE. The primary component is SOLIFENACIN SUCCINATE.

    Product Information

    NDC 42291-0739
    Product ID 42291-739_0e99218f-04ce-60b0-e063-6294a90afb7f
    Associated GPIs 54100055200320
    GCN Sequence Number 057982
    GCN Sequence Number Description solifenacin succinate TABLET 5 MG ORAL
    HIC3 R1I
    HIC3 Description URINARY TRACT ANTISPASMODIC, M(3) SELECTIVE ANTAG.
    GCN 23276
    HICL Sequence Number 026595
    HICL Sequence Number Description SOLIFENACIN SUCCINATE
    Brand/Generic Generic
    Proprietary Name Solifenacin Succinate
    Proprietary Name Suffix n/a
    Non-Proprietary Name solifenacin succiate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 5
    Active Ingredient Units mg/1
    Substance Name SOLIFENACIN SUCCINATE
    Labeler Name AvKARE
    Pharmaceutical Class Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA210281
    Listing Certified Through 2025-12-31

    Package

    NDC 42291-0739-30 (42291073930)

    NDC Package Code 42291-739-30
    Billing NDC 42291073930
    Package 30 TABLET, FILM COATED in 1 BOTTLE (42291-739-30)
    Marketing Start Date 2020-10-01
    NDC Exclude Flag N
    Pricing Information N/A